Champalimaud Foundation

Error creating thumbnail:

Champalimaud Foundation building

Champalimaud Foundation is a private biomedical research foundation, which aims to support the development of medical science. It was established in 2004 by the last will and testament of António de Sommer Champalimaud, a Portuguese entrepreneur and industrialist. The foundation is headquartered in Lisbon, Portugal, and focuses on cutting-edge research in the fields of neuroscience and oncology.

History

The Champalimaud Foundation was created following the death of António Champalimaud in 2004. Champalimaud was one of Portugal's wealthiest individuals, and he dedicated a significant portion of his fortune to the establishment of a foundation that would contribute to the advancement of medical science. The foundation was officially inaugurated in 2010 with the opening of the Champalimaud Centre for the Unknown, a state-of-the-art research facility located on the waterfront in Lisbon.

Champalimaud Centre for the Unknown

The Champalimaud Centre for the Unknown serves as the main hub for the foundation's research activities. Designed by the Indian architect Charles Correa, the center is a visually striking building that has won several architectural awards. It houses research laboratories, clinical facilities, and auditoriums, providing a multidisciplinary environment for scientists and clinicians to collaborate.

Research

The foundation's research efforts are primarily focused on the fields of neuroscience and oncology, with the goal of understanding the underlying mechanisms of brain function and cancer. Researchers at the Champalimaud Foundation employ a variety of techniques, from molecular biology to behavioral science, to investigate these complex systems.

Neuroscience

In neuroscience, the foundation's researchers explore topics such as neural circuits, sensory perception, and brain plasticity. Their work aims to uncover the neural basis of behavior and cognition, with potential applications in the treatment of neurological disorders.

Oncology

In oncology, the foundation is dedicated to the development of new diagnostic and therapeutic strategies for cancer. This includes research on tumor biology, immunotherapy, and the identification of biomarkers for cancer detection and treatment.

Education and Training

The Champalimaud Foundation is also committed to education and training in the biomedical sciences. It offers a range of programs, including PhD and postdoctoral fellowships, workshops, and conferences, designed to foster the next generation of scientists and clinicians.

Champalimaud Vision Award

The foundation is known for the Champalimaud Vision Award, one of the world's largest scientific prizes, which is awarded annually to groups or individuals who have made significant contributions to the understanding and preservation of vision.

Conclusion

The Champalimaud Foundation stands as a beacon of biomedical research, with its innovative approach to understanding and treating some of the most challenging diseases facing humanity. Through its state-of-the-art facilities and commitment to scientific excellence, the foundation continues to make significant strides in neuroscience and oncology research.